Prohibition Partners

Prohibition Partners · Free weekly briefing

International Cannabis Weekly

The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.

369

6 regions27 stories11 countries

← №368All issues370

Top story

Spain proposes regulations for long-awaited medical cannabis framework

Spanish regulators have taken another step towards introducing the country’s long-delayed medical cannabis framework, but patients say the legislation doesn’t go far enough.

ESMedicallink no longer available

  1. 01

    Proposal could see CBD banned for use in cosmetics across Europe

    EUHemp & CBDlink no longer available

  2. 02

    Top Democrats urge DEA to swiftly reschedule cannabis

    USRegulationlink no longer available

Europe

6 stories
  • Italian farmers call on European Parliament to suspend CBD narcotic measures

    ITHemp & CBDlink no longer available

  • Malta to ban all HHC products to protect children and public health

    MTRegulationlink no longer available

  • UK CBD regulations in spotlight as industry calls for transparency

    GBHemp & CBDlink no longer available

  • £350K funding awarded for UK medical cannabis pharmaceutical plant study

    GBMedicallink no longer available

  • Ukraine publishes official list of approved medical cannabis conditions

    UAMedicallink no longer available

  • Isle of Man GrowLab Organics resubmits medical cannabis HQ plans

    GBBusiness & Investmentlink no longer available

United States

6 stories
  • California governor approves Amsterdam-style consumption cafes

    USAdult-uselink no longer available

  • Top GOP Pennsylvania senator expresses support for cannabis decriminalisation

    USRegulationlink no longer available

  • Ohio adult-use cannabis sales exceed US$76 million in under 50 days

    USAdult-uselink no longer available

  • Michigan adult-use sales boom fuelled by low flower prices near US$80

    USAdult-uselink no longer available

  • Minnesota Office of Cannabis Management shares social equity licence data

    USRegulationlink no longer available

  • Trulieve partners with Black Buddha Cannabis for Arizona and Pennsylvania

    USBusiness & Investmentlink no longer available

Canada

4 stories
  • Canadian cannabis industry seeks change under outdated tax regime

    CARegulationlink no longer available

  • Canadian cannabis leaders voice concerns near Parliament building in Ottawa

    CAEvents & Industrylink no longer available

  • High Tide Cannabis Co. ranks among Canada's top-growing businesses

    CABusiness & Investmentlink no longer available

  • Bubble Bud Inc. urges Health Canada to act on beverage testing deficiencies

    CARegulationlink no longer available

LATAM & Caribbean

4 stories
  • Brazil's ANVISA makes updates to cannabis product import system

    BRRegulationlink no longer available

  • Argentina's INASE classifies new categories for hemp seed inspection

    ARHemp & CBDlink no longer available

  • Argentina's National Commission sets new hemp sector salary scales

    ARHemp & CBDlink no longer available

  • Premier Graphene's affiliate advances industrial hemp in Mexico joint venture

    MXBusiness & Investmentlink no longer available

Africa & Middle East

1 story
  • South Africa at crucial juncture as global medical cannabis interest grows

    ZAMedicallink no longer available

Oceania

3 stories
  • Cann Group tells ASX positive coverage could drive share price surge

    AUBusiness & Investmentlink no longer available

  • South Australia could exempt medical cannabis patients from drug driving laws

    AURegulationlink no longer available

  • East African gold mine paves way for cannabis facility in rural Australia

    AUBusiness & Investmentlink no longer available

Never miss an issue

International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.

From the research library

Global Medical Cannabis Market Review

14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.

From £1,265

View report